101 related articles for article (PubMed ID: 8355178)
1. Myocardial uptake and pharmacodynamics of procainamide in patients with coronary heart disease and sustained ventricular tachyarrhythmias.
Gillis AM; Duff HJ; Mitchell LB; Wyse DG
J Pharmacol Exp Ther; 1993 Aug; 266(2):1001-6. PubMed ID: 8355178
[TBL] [Abstract][Full Text] [Related]
2. Myocardial uptake kinetics and pharmacodynamics of propafenone in the isolated perfused rabbit heart.
Gillis AM; Kates RE
J Pharmacol Exp Ther; 1986 Jun; 237(3):708-12. PubMed ID: 3712276
[TBL] [Abstract][Full Text] [Related]
3. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
[TBL] [Abstract][Full Text] [Related]
4. Effect of hyperinsulinemia on myocardial amino acid uptake in patients with coronary artery disease.
McNulty PH; Jacob R; Deckelbaum LI; Young LH
Metabolism; 2000 Oct; 49(10):1365-9. PubMed ID: 11079831
[TBL] [Abstract][Full Text] [Related]
5. Interaction of bisoprolol and procainamide in human cardiac impulse generation and conduction.
Verrostte JM; van Hemel NM; Kingma JH
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S193-5. PubMed ID: 11527128
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an open-loop, computer-based infusion system designed to achieve a series of constant, targeted plasma procainamide concentrations in patients undergoing electrophysiologic testing.
Coyle JD; Carnes CA; Schaal SF
Pharmacotherapy; 1997; 17(3):445-56. PubMed ID: 9165549
[TBL] [Abstract][Full Text] [Related]
7. The electrophysiologic effects of procainamide in the immature heart.
Shih JY; Gillette PC; Kugler JD; Garson A; Fukushige J; Zinner A; Driscoll DJ
Pediatr Pharmacol (New York); 1982; 2(1):65-73. PubMed ID: 7110758
[TBL] [Abstract][Full Text] [Related]
8. The discordant influences of infarct healing on the electrophysiologic effects of procainamide and N-acetylprocainamide.
Nelson SD; Coyne KS; Meimer J
J Pharmacol Exp Ther; 1995 Apr; 273(1):315-9. PubMed ID: 7536244
[TBL] [Abstract][Full Text] [Related]
9. Immediate quantitation of antiarrhythmic drug effect by monophasic action potential recording in coronary artery disease.
Platia EV; Weisfeldt ML; Franz MR
Am J Cardiol; 1988 Jun; 61(15):1284-7. PubMed ID: 3376887
[TBL] [Abstract][Full Text] [Related]
10. Effects of prostacyclin on myocardial hemodynamics and metabolism after coronary artery bypass grafting.
Kieler-Jensen N; Milocco I; Kirnö K; Houltz E; Ricksten SE
J Cardiothorac Vasc Anesth; 1996 Oct; 10(6):741-7. PubMed ID: 8910153
[TBL] [Abstract][Full Text] [Related]
11. Conversion from intravenous procainamide to oral sustained release tablets in cardiac patients.
Kalin ML; Babich MF; Klinke WP; Hui WK
Can J Cardiol; 1990; 6(1):15-8. PubMed ID: 2310989
[TBL] [Abstract][Full Text] [Related]
12. Acute cardiovascular effects of magnesium and their relationship to systemic and myocardial magnesium concentrations after short infusion in awake sheep.
Zheng D; Upton RN; Ludbrook GL; Martinez A
J Pharmacol Exp Ther; 2001 Jun; 297(3):1176-83. PubMed ID: 11356944
[TBL] [Abstract][Full Text] [Related]
13. [Myocardial microcirculation in humans--new approaches using MRI].
Wacker CM; Bauer WR
Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
[TBL] [Abstract][Full Text] [Related]
14. Propafenone disposition and pharmacodynamics in normal and norepinephrine-induced cardiomyopathic rabbit hearts.
Gillis AM; Lester WM; Keashly R
J Pharmacol Exp Ther; 1991 Aug; 258(2):722-7. PubMed ID: 1865368
[TBL] [Abstract][Full Text] [Related]
15. Heart rate variability in patients suffering from structural heart disease and decreased AV-nodal conduction capacity. Insights into the formation of heart rate variability.
Schwab JO; Eichner G; Schmitt H; Schrickel J; Yang A; Balta O; Lüderitz B; Lewalter T
Z Kardiol; 2004 Mar; 93(3):229-33. PubMed ID: 15024591
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics of procainamide in patients with ventricular tachyarrhythmias.
Liem LB; Yee YG; Swerdlow CD; Kates RE
J Clin Pharmacol; 1988 Nov; 28(11):984-9. PubMed ID: 3243920
[TBL] [Abstract][Full Text] [Related]
17. Myocardial procainamide concentration in canine atria and ventricles.
Wenger TL; Masterton CE; Abou-Donia MB; Bache RJ; Strauss HC
J Cardiovasc Pharmacol; 1979; 1(1):155-61. PubMed ID: 94377
[TBL] [Abstract][Full Text] [Related]
18. Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake.
Michaels AD; McKeown B; Kostal M; Vakharia KT; Jordan MV; Gerber IL; Foster E; Chatterjee K
Circulation; 2005 Mar; 111(12):1504-9. PubMed ID: 15781741
[TBL] [Abstract][Full Text] [Related]
19. Ventricular tachycardia with QRS configuration similar to that in sinus rhythm and a myocardial origin: differential diagnosis with bundle branch reentry.
Guo H; Hecker S; Lévy S; Olshansky B
Europace; 2001 Apr; 3(2):115-23. PubMed ID: 11333048
[TBL] [Abstract][Full Text] [Related]
20. The relationship between the myocardial kinetics of meperidine and its effect on myocardial contractility: model-independent analysis and optimal regional model.
Upton RN; Huang YF; Mather LE; Doolette DJ
J Pharmacol Exp Ther; 1999 Aug; 290(2):694-701. PubMed ID: 10411580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
